Abbonarsi

Neurodevelopmental Outcomes at Two Years’ Corrected Age of Very Preterm Infants after Implementation of a Post-Discharge Responsive Parenting Intervention Program (TOP Program) - 17/06/23

Doi : 10.1016/j.jpeds.2023.02.025 
Nienke M. Halbmeijer, MD 1, 2, Martine Jeukens-Visser, PhD 2, 3, Wes Onland, PhD 1, 2, Monique Flierman, MSc 2, 3, Anton H. van Kaam, PhD 1, 2, Aleid Leemhuis, PhD 1, 2,
on behalf of the

SToP-BPD and the TOP program study group

  A complete list of study group members appears in the acknowledgments.

1 Department of Neonatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands 
2 Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands 
3 Department of Rehabilitation, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands 

Reprint requests: Aleid Leemhuis, PhD, Department of Neonatology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. Department of Neonatology Amsterdam UMC location University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands

Abstract

Objective

To compare neurodevelopmental outcomes at 2 years corrected age (CA) between infants born very preterm (VP) who did or did not receive a postdischarge responsive parenting intervention (Transmural developmental support for very preterm infants and their parents [TOP program]) between discharge home and 12 months’ CA.

Study design

The Systemic Hydrocortisone to Prevent Bronchopulmonary Dysplasia (SToP-BPD) study showed no differences between treatment groups in motor and cognitive development using the Dutch Bayley Scales of Infant Development and behavior using the Child Behavior Checklist at 2 years’ CA. During its study period, the TOP program was gradually scaled up nationwide in the same population, providing an opportunity to evaluate the effect of this program on neurodevelopmental outcome, after adjusting for baseline differences.

Results

Among 262 surviving VP infants in the SToP-BPD study, 35% received the TOP program. Infants in the TOP group had a significantly lower incidence of a cognitive score < 85 (20.3% vs 35.2%; adjusted absolute risk reduction: −14.1% [95% CI: −27.2 to −1.1]; P  = .03), and a significantly higher mean cognitive score (96.7 ± 13.8), compared with the non-TOP group (92.0 ± 17.5; crude mean difference: 4.7 [95% CI: 0.3 to 9.2]; P  = .03). No significant differences were found on motor scores. For behavior problems, a small but statistically significant effect for anxious/depressive problems was found in the TOP group (50.5 vs 51.2; P  = .02).

Conclusions

VP infants supported by the TOP program from discharge until 12 months’ CA had better cognitive function at 2 years’ CA. This study demonstrates a sustained positive effect of the TOP program in VP infants.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : very preterm infants, early intervention programs, neurodevelopmental outcomes

Abbreviations : Bayley-III-NL, BPD, CA, CBCL1½−5, CCS, CMS, DSM-IV, GA, NICU, RCT, SToP-BPD, TOP, VP


Mappa


 Funding/Support: The SToP-BPD study was funded by a Project Grant from The Netherlands Organization for Health Research and Development, ZonMW Priority Medicines for Children, no. 11-32010-02. The funding agency had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
 The authors declare no conflicts of interest.
  Clinical Trial Registration: The SToP-BPD study was registered with the Netherlands Trial Register (NTR2768; registered on 17 February 2011; 2640 ) and the European Union Clinical Trials Register (EudraCT, 2010-023777-19; registered on 2 November 2010; NL ).
 The results of this study were presented at the Pediatric Academic Societies Meeting 2022, Denver, United States; poster presentation; April 22, 2022.


© 2023  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 257

Articolo 113381- giugno 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Discriminating Young Children with Concussion in an Outpatient Specialty Clinic from Healthy Controls Using the Child Sports Concussion Assessment Tool-5
  • Alicia M. Trbovich, Vanessa Fazio-Sumrok, Jonathan Preszler, Madelyn A. Shaffer, Nathan Kegel, Alicia Kissinger-Knox, Michael W. Collins, Anthony P. Kontos
| Articolo seguente Articolo seguente
  • Effect of Presenting Survival Information as Text or Pictograph During Periviable Birth Counseling: A Randomized, Controlled Trial
  • Siobhan M. McDonnell, Mir A. Basir, Ke Yan, Melodee Nugent Liegl, Paul D. Windschitl

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.